NCT02225301 iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
| NCT ID | NCT02225301 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Milton S. Hershey Medical Center |
| Condition | Child Abuse |
| Study Type | INTERVENTIONAL |
| Enrollment | 35,000 participants |
| Start Date | 2014-11-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 35,000 participants in total. It began in 2014-11-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Phase 1 was a randomized control trial that used a test-retest model to evaluate the impact of iLook Out for Child Abuse, an online, interactive learning module about reporting suspected child abuse. Delivered via a learning management system to early childhood professionals who work with infants and young children, this study assessed iLookOut's effect on 1) knowledge about reporting suspected child abuse; 2) attitudes toward reporting suspected child abuse; and 3) preparedness to protect children at risk. Findings from Phase 1 were that iLookOut will improved knowledge, changed attitudes, and increase self-reported preparedness of early childhood providers to report suspected child abuse. Phase 2 of this trial is an open-enrollment study that records pre-/post- data on the same measurements as Phase 1, and is available for use (free of charge) for all childcare providers in Pennsylvania at https://www.ilookoutforchildabuse.com.
Eligibility Criteria
Inclusion Criteria: * Paid or volunteer staff at childcare facility Exclusion Criteria: * Younger than 18 years of age
Contact & Investigator
Benjamin H Levi, MD PhD
PRINCIPAL INVESTIGATOR
Penn State Milton S. Hershey Medical Center / Penn State College of Medicine
Frequently Asked Questions
Who can join the NCT02225301 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Child Abuse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02225301 currently recruiting?
Yes, NCT02225301 is actively recruiting participants. Contact the research team at nverdiglione@hmc.psu.edu for enrollment information.
Where is the NCT02225301 trial being conducted?
This trial is being conducted at Hershey, United States.
Who is sponsoring the NCT02225301 clinical trial?
NCT02225301 is sponsored by Milton S. Hershey Medical Center. The principal investigator is Benjamin H Levi, MD PhD at Penn State Milton S. Hershey Medical Center / Penn State College of Medicine. The trial plans to enroll 35,000 participants.